297 related articles for article (PubMed ID: 16968899)
41. Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.
Yang X; Gao M; Chen G; Pierce BG; Lu J; Weng NP; Mariuzza RA
J Biol Chem; 2015 Nov; 290(48):29106-19. PubMed ID: 26429912
[TBL] [Abstract][Full Text] [Related]
42. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
Knutson KL; Disis ML
Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
[TBL] [Abstract][Full Text] [Related]
43. Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer.
Parlar A; Sayitoglu EC; Ozkazanc D; Georgoudaki AM; Pamukcu C; Aras M; Josey BJ; Chrobok M; Branecki S; Zahedimaram P; Ikromzoda L; Alici E; Erman B; Duru AD; Sutlu T
Eur J Immunol; 2019 Aug; 49(8):1278-1290. PubMed ID: 31054264
[TBL] [Abstract][Full Text] [Related]
44. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
45. Signaling efficiency of the T cell receptor controlled by a single amino acid in the beta chain constant region.
Bäckström BT; Hausmann BT; Palmer E
J Exp Med; 1997 Dec; 186(11):1933-8. PubMed ID: 9382891
[TBL] [Abstract][Full Text] [Related]
46. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
47. A conserved αβ transmembrane interface forms the core of a compact T-cell receptor-CD3 structure within the membrane.
Krshnan L; Park S; Im W; Call MJ; Call ME
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6649-E6658. PubMed ID: 27791034
[TBL] [Abstract][Full Text] [Related]
48. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
49. An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.
Knies D; Klobuch S; Xue SA; Birtel M; Echchannaoui H; Yildiz O; Omokoko T; Guillaume P; Romero P; Stauss H; Sahin U; Herr W; Theobald M; Thomas S; Voss RH
Oncotarget; 2016 Apr; 7(16):21199-221. PubMed ID: 27028870
[TBL] [Abstract][Full Text] [Related]
50. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
51. A yeast surface display system for the discovery of ligands that trigger cell activation.
Cho BK; Kieke MC; Boder ET; Wittrup KD; Kranz DM
J Immunol Methods; 1998 Nov; 220(1-2):179-88. PubMed ID: 9839939
[TBL] [Abstract][Full Text] [Related]
52. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
Clay TM; Custer MC; Spiess PJ; Nishimura MI
Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
[TBL] [Abstract][Full Text] [Related]
53. Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen.
Luo W; Zhang XB; Huang YT; Hao PP; Jiang ZM; Wen Q; Zhou MQ; Jin Q; Ma L
J Mol Med (Berl); 2011 Sep; 89(9):903-13. PubMed ID: 21556811
[TBL] [Abstract][Full Text] [Related]
54. [Transgenic expression of T cell receptors on HBV-specific cytotoxic T lymphocytes].
Wu J; Wang L; Liu Y; Ye H; Ding N; Liu Y; Xu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):453-7. PubMed ID: 23643259
[TBL] [Abstract][Full Text] [Related]
55. Regulator T cells: specific for antigen and/or antigen receptors?
Rubin B; de Durana YD; Li N; Sercarz EE
Scand J Immunol; 2003 May; 57(5):399-409. PubMed ID: 12753496
[TBL] [Abstract][Full Text] [Related]
56. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
Yrlid U; Petersson E; Dohlsten M; Hedlund G
Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889
[TBL] [Abstract][Full Text] [Related]
57. A TCR-based Chimeric Antigen Receptor.
Walseng E; Köksal H; Sektioglu IM; Fåne A; Skorstad G; Kvalheim G; Gaudernack G; Inderberg EM; Wälchli S
Sci Rep; 2017 Sep; 7(1):10713. PubMed ID: 28878363
[TBL] [Abstract][Full Text] [Related]
58. T cell receptor diversity in CTLs specific for the CTT-1 and CTT-2 minor histocompatibility antigens.
Johnston SL; Wettstein PJ
J Immunol; 1997 Sep; 159(6):2606-15. PubMed ID: 9300679
[TBL] [Abstract][Full Text] [Related]
59. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
Kuhröber A; Schirmbeck R; Reimann J
Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
[TBL] [Abstract][Full Text] [Related]
60. Alloreactive anti-HLA-B7 cytolytic T cell clones use restricted T cell receptor genes.
Li YY; Smith KD; Shi Y; Lutz CT
Transplantation; 1996 Oct; 62(7):954-61. PubMed ID: 8878390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
